ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1alpha-Puro (Plasmid)

Product Description

Quickly and reliably create cells expressing ACE2 to advance your studies of the receptor’s role in SARS-CoV-2 infection and normal physiology

• Leverage SBI’s robust lentivector expression technology to study the ACE2 receptor
• Choose ready-to-package plasmid or ready-to-transduce virus
• Also available as a stable HEK293 cell line

ACE2 Expression Lentivector is based on our robust pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector (Cat.# CD510B-1/VA-1-SBI), and delivers ACE2 expression from the CMV promoter, with a separate EF1α promoter driving the expression of the puromycin resistance gene for selection. Available in both plasmid and pre-packaged lentivirus formats, the ACE2 Expression Lentivector enables a wide range of studies using the systems of your choice.